Operating Lease, Right-of-Use Asset of Kronos Bio, Inc. from 31 Dec 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kronos Bio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 31 Mar 2025.
  • Kronos Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $3,048,000, a 78% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Kronos Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,048,000 -$10,854,000 -78% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $3,176,000 -$16,481,000 -84% 31 Dec 2024 10-Q 08 May 2025 2025 Q1
Q3 2024 $12,269,000 -$8,185,000 -40% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $12,830,000 -$8,421,000 -40% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $13,902,000 -$10,221,000 -42% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $19,657,000 -$5,050,000 -20% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $20,454,000 -$4,822,000 -19% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $21,251,000 -$4,579,000 -18% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $24,123,000 -$2,247,000 -8.5% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $24,707,000 -$2,197,000 -8.2% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $25,276,000 -$2,157,000 -7.9% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $25,830,000 -$2,127,000 -7.6% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $26,370,000 +$1,525,000 +6.1% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $26,904,000 -$418,000 -1.5% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $27,433,000 -$1,922,000 -6.5% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $27,957,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $24,845,000 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $27,322,000 +$26,849,000 +5676% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $29,355,000 30 Sep 2020 10-Q 18 Nov 2020 2020 Q3
Q4 2019 $473,000 31 Dec 2019 10-K 23 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.